Dhaman: Arab Countries See 44% Increase in Trade, Investment Insurance Operations

Dhaman held the 50th meeting of its board of shareholders in Rabat on Saturday. (Asharq Al-Awsat)
Dhaman held the 50th meeting of its board of shareholders in Rabat on Saturday. (Asharq Al-Awsat)
TT

Dhaman: Arab Countries See 44% Increase in Trade, Investment Insurance Operations

Dhaman held the 50th meeting of its board of shareholders in Rabat on Saturday. (Asharq Al-Awsat)
Dhaman held the 50th meeting of its board of shareholders in Rabat on Saturday. (Asharq Al-Awsat)

The Arab Investment & Export Credit Guarantee Corporation (Dhaman) said that the total value of intra-Arab trade, finance and investment insurance services increased by 44 percent to reach around $3 billion in 2022, compared to about $2.1 billion in 2021.

Speaking on behalf of the chairman of Dhaman board of directors, Dr. Naif bin Abdul Rahman Al-Shammari, at the 50th meeting of Dhaman board of shareholders in Rabat on Saturday, Board Member Ambassador Jamal Al-Ghanim said the total value of insurance premiums increased by 7.97 percent to more than $7.6 million compared to their value in 2021.

The Corporation’s balance sheet for the past year showed an increase in the Dhaman assets to $536.2 million, and a rise in property rights to about $508.5 million, while total revenues amounted to about $16.2 million and profits approached $6 million, according to a statement on Saturday.

Al-Shammari pointed to the institution’s achievements in 2022, including efforts to market insurance services, the signing of four memorandums of understanding with Arab and international bodies, and the development of the institution’s role in the field of research and awareness raising.

Based in Kuwait, the Dhaman was established in 1974 as a pan-Arab organization owned by the governments of Arab states and 4 Arab financial institutions, and provides multilateral investment guarantee.

Its objectives include promoting the flow of foreign direct investment (FDI) into Arab countries by providing political risk insurance to Arab and non-Arab investors and lenders, enhancing Arab exports through political and commercial risk insurance to Arab exporters and supporting domestic trade and economic growth.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.